The Future of Television Audience Measurement: Nielsen Media Research's View

2002 ◽  
Vol 105 (1) ◽  
pp. 49-54
Author(s):  
Ian Garland

Changing television delivery technology has presented huge challenges to the industry charged with tracking audience usage. Niche programming and personal recording technologies are making the concept of mass audiences increasingly problematic. This raises questions about how to capture exactly what the illusive viewer is doing in a way that is relevant to media buyers, advertisers and media companies. In this paper. Ian Garland reports on how Nielsen Media Research is tackling the problem.

2021 ◽  
Vol 27 (3) ◽  
pp. 765-777
Author(s):  
Juan Pablo Artero-Muñoz ◽  
Ricardo Zugasti ◽  
Sira Hernánez-Corchete

In Spain, the media market structure is made up of very different media groups, making it necessary to identify and classify them in a clear and coherent manner. To do so, this article collects secondary information from media companies’ websites and from audience measurement institutions. Results identify 50 media groups with activity in the Spanish market. They are classified into three categories according to the type of outlet, including national, sectorial, and regional. The current structure is based on recent developments in the last four decades of democracy among newspapers, magazines, radio, television and digital media.


2020 ◽  
Vol 2020 (0) ◽  
pp. 1-23 ◽  
Author(s):  
Ana González-Neira ◽  
◽  
Natalia Quintas-Froufe ◽  
Jorge Gallardo-Camacho ◽  
◽  
...  

2020 ◽  
Vol 10 (21) ◽  
pp. 7654
Author(s):  
Junwei Wei ◽  
Nan Peng ◽  
Yunxiang Liang ◽  
Keke Li ◽  
Yingjun Li

Antibiotic-resistant bacteria infections pose a threat to public health. Considering the difficulty in developing new antibiotics, it is an urgent need to develop alternative therapies against bacterial pathogens. Bacteriophages (phages) are evaluated as potential substitutes or adjuncts of antibiotics because they are abundant in nature and could specifically lyse bacteria. In this review, we briefly introduce phage therapy and its advantages compared with traditional antibiotic therapy. We also summarize new emerging phage technologies, such as CRISPR-Cas, synthetic phages, etc., and discuss some possible obstacles and potential risks in the application process. We believe that, with the advancement in synthetic biology and delivery technology, phage therapy has broad prospects in the future.


2011 ◽  
Vol 33 (5) ◽  
pp. 791-800 ◽  
Author(s):  
Jérôme Bourdon ◽  
Cécile Méadel

Author(s):  
Debnath Mukherjee ◽  
Tanushyam Chattopadhyay ◽  
Siddharth Bhattacharya ◽  
Avik Ghose ◽  
Prateep Misra

Sign in / Sign up

Export Citation Format

Share Document